Assignee
BENITEC BIOPHARMA LTD
AU·9 granted patents·4 pending applications·14 citations·filing 2013–2020
Top patents by PatentIndex Score
13 records- 0183US11142765B2Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereofBENITEC BIOPHARMA LTD·Filed 2017·Granted Oct 12, 2021·3 cites·27 claims
- 0283US10898505B2Reagents for treatment of hepatitis B virus (HBV) infection and use thereofBENITEC BIOPHARMA LTD·Filed 2016·Granted Jan 26, 2021·3 cites·20 claims
- 0377US11535851B2Reagents for treatment of hepatitis B virus (HBV) infection and use thereofBENITEC BIOPHARMA LTD·Filed 2017·Granted Dec 27, 2022·1 cites·23 claims
- 0477US11499141B2Adeno-associated virus (AAV) with modified phospholipase domainBENITEC BIOPHARMA LTD·Filed 2018·Granted Nov 15, 2022·2 cites·20 claims
- 0577US9518260B2Pain treatmentBENITEC BIOPHARMA LTD·Filed 2013·Granted Dec 13, 2016·3 cites·25 claims
- 0665US10000753B2Age-related macular degeneration treatmentBENITEC BIOPHARMA LTD·Filed 2014·Granted Jun 19, 2018·1 cites·23 claims
- 0763US11234994B2Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereofBENITEC BIOPHARMA LTD·Filed 2017·Granted Feb 1, 2022·1 cites·21 claims
- 0860US2021177885A1Reagents for treatment of hepatitis b virus (hbv) infection and use thereofBENITEC BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 0947US2022106594A1Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD)BENITEC BIOPHARMA LTD·Filed 2019·Application pending·0 cites
- 1044US2018320180A1Age-related macular degeneration treatmentBENITEC BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 1143US9410154B2HBV treatmentBENITEC BIOPHARMA LTD·Filed 2015·Granted Aug 9, 2016·0 cites·20 claims
- 1240US9790502B2HBV treatmentBENITEC BIOPHARMA LTD·Filed 2016·Granted Oct 17, 2017·0 cites·26 claims
- 1337US2019309307A1REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOFBENITEC BIOPHARMA LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →